在选择性FLT3抑制剂生成的变化自编码器的潜空间内贝叶斯优化
Raghav Chandra1, Robert I Horne1, Michele Vendruscolo1
1Centre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, U.K.
这项研究引入了一种深度学习方法,将生成模型和贝叶斯优化相结合,以实现更快,更便宜的药物设计. 该方法有效地识别出具有高向亲和力和选择性的小分子,与已批准的药物相比.
科学领域:
- 药用化学 医学化学
- 计算化学计算化学
- 药物发现 药物发现 药物发现
背景情况:
- 药物设计需要识别高亲和度,选择性化合物.
- 基于深度学习的生成模型提供了有效的药物发现途径.
- 优化化学空间探索对于识别有效的药物候选人至关重要.
研究的目的:
- 开发一种用于加速药物设计的新型计算框架.
- 整合生成型深度学习模型与贝叶斯优化,用于化学空间探索.
- 优化小分子以获得高目标亲和力和选择性.
主要方法:
- 使用交叉树变异自编码器 (JTVAE) 进行分子生成.
- 使用贝叶斯优化来导航JTVAE隐藏空间.
- 实现一个目标函数以最大限度地实现目标绑定并最大限度地减少目标之外的相互作用.
主要成果:
- 该框架成功识别了具有预测高亲和力和选择性的小分子.
- 在FMS类型的氨酸激酶3 (FLT3) 抑制的背景下证明有效性.
- 预测的化合物性能与FLT3的临床批准药物相当.
结论:
- 拟议的深度学习框架加快了强大和有选择性的候选药物的识别.
- 这种方法为早期药物发现提供了更快,更具成本效益的替代方案.
- 该方法对开发针对FLT3.3等特定激酶的新疗法充满希望.
更多相关视频
09:47Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
09:20Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants
Published on: October 18, 2022
相关概念视频
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
On...
Randomized Experiments
Simple randomization
Simple...
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
Improving Translational Accuracy
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
